Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;34(11):e686-e689.
doi: 10.1111/jdv.16775. Epub 2020 Jul 20.

Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature

S Matar  1 , B Oulès  1   2   3 , P Sohier  2   4 , O Chosidow  5   6 , M Beylot-Barry  7   8 , N Dupin  1   2   3 , S Aractingi  1   2   3
Affiliations

Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature

S Matar et al. J Eur Acad Dermatol Venereol. 2020 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Prof. Dupin, Dr. Matar and Dr. Sohier have nothing to disclose. Dr. Oulès reports personal fees from Novartis, outside the submitted work. Prof. Chosidow is a PI for PSOBIOTEQ. Prof. Beylot‐Barry reports personal fees from AbbVie, Celgene, Takeda, Janssen, Novartis, and Lilly, outside the submitted work. Prof. Aractingi reports grants from Novartis and Leo Pharma, and personal fees from Pierre Fabre, BMS and Lilly, outside the submitted work.

Figures

Figure 1
Figure 1
(a) Analysis of the incidence of cutaneous manifestations related to COVID‐19. (b) Pneumonia, hospital admission, transfer to CCU and death were analysed in patients of the WHOLE cohort presenting with rash or chilblains. Chi‐square test. *P‐value < 0.05; ****P‐value < 0.0001.
See this image and copyright information in PMC

References

    1. Sanchez A, Sohier P, Benghanem S et al. Digitate papulosquamous eruption associated with severe acute respiratory syndrome coronavirus 2 infection. JAMA Dermatol 2020. 10.1001/jamadermatol.2020.1704 - DOI - PubMed
    1. Recalcati S, Barbagallo T, Frasin LA et al. Acral cutaneous lesions in the time of COVID‐19. J Eur Acad Dermatology Venereol 2020. 10.1111/jdv.16533 - DOI - PMC - PubMed
    1. Piccolo V, Neri I, Filippeschi C et al. Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patients. J Eur Acad Dermatology Venereol 2020. 10.1111/jdv.16526 - DOI - PMC - PubMed
    1. Fernandez‐Nieto D, Jimenez‐Cauhe J, Suarez‐Valle A et al. Characterization of acute acro‐ischemic lesions in non‐hospitalized patients: a case series of 132 patients during the COVID‐19 outbreak. J Am Acad Dermatol 2020. 10.1016/j.jaad.2020.04.093 - DOI - PMC - PubMed
    1. Galván Casas C, Català A, Carretero Hernández G et al. Classification of the cutaneous manifestations of COVID‐ 19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020. 10.1111/bjd.19163 - DOI - PMC - PubMed